(Q37850740)

24 August 2017

1 reference

title

Proteomic analysis of soft tissue sarcoma (English)

1 reference

24 August 2017

Yoshiyuki Suehara

1

1 reference

24 August 2017

publication date

9 March 2011

1 reference

International Journal of Clinical Oncology

24 August 2017

published in

1 reference

24 August 2017

volume

16

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

92-100

1 reference

Gene expression profiling in sarcomas

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Chromosomal and genetic imbalances in synovial sarcoma detected by conventional and microarray comparative genomic hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

A gene expression signature associated with metastatic outcome in human leiomyosarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Molecular profiling in the diagnosis and treatment of high grade sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Global protein-expression analysis of bone and soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Microarray analysis of sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Correlation between protein and mRNA abundance in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Discordant protein and mRNA expression in lung adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Proteomic patterns of tumour subsets in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Proteomic analysis of human acute leukemia cells: insight into their classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Proteomic evaluation of archival cytologic material using SELDI affinity mass spectrometry: potential for diagnostic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Proteomic profiling in musculoskeletal oncology by MALDI mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

An overview of lung cancer genomics and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Prognostic significance of mast cells in soft tissue sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Gastrointestinal stromal tumor: 5 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Cyclin D3 immunoreactivity in gastrointestinal stromal tumors is independent of cyclin D3 gene amplification and is associated with nuclear p27 accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Molecular targets for tumour progression in gastrointestinal stromal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Isolation from cochlea of a novel human intronless gene with predominant fetal expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Molecular characterisation of soft tissue tumours: a gene expression study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-011-0203-9

Comparative proteomics analysis of human osteosarcomas and benign tumor of bone

21 January 2018

1 reference

12 December 2020

Proteomic strategies and their application in cancer research

1 reference

12 December 2020

Proteomic signatures corresponding to histological classification and grading of soft-tissue sarcomas

1 reference

12 December 2020

DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance

1 reference

12 December 2020

Pfetin as a prognostic biomarker in gastrointestinal stromal tumor: novel monoclonal antibody and external validation study in multiple clinical facilities

1 reference

12 December 2020

Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray.

1 reference

12 December 2020

Peroxiredoxin 2 as a chemotherapy responsiveness biomarker candidate in osteosarcoma revealed by proteomics

1 reference

12 December 2020

Survival in synovial sarcoma. A multivariate study of prognostic factors with special emphasis on the comparison between early death and long-term survival

1 reference

12 December 2020

Application of 2D-DIGE in cancer proteomics toward personalized medicine

1 reference

12 December 2020

Secernin-1 as a novel prognostic biomarker candidate of synovial sarcoma revealed by proteomics

1 reference

12 December 2020

Gene expression profiling of synovial sarcoma: distinct signature of poorly differentiated type.

1 reference

12 December 2020

Molecular classification of borderline ovarian tumors using hierarchical cluster analysis of protein expression profiles

1 reference

12 December 2020

Aberrant expression of glycosylation in juvenile gastrointestinal stromal tumors

1 reference

12 December 2020

10.1007/S10147-011-0203-9

Identifiers

DOI

1 reference

24 August 2017

1 reference